0
Information for Healthcare Professionals
Indications

XAXAX XR Tablets are indicated for the treatment of panic disorder, with or without agoraphobia.

XANAX XR can effectively reduce the occurrence of panic attacks, which include repeated periods of intense fear accompanied by 4 or more of the following symptoms:

  • Chest pain or discomfort
  • Chills or hot flushes
  • Feeling of choking
  • Feeling dizzy, unsteady, light-headed, or faint
  • Nausea or abdominal distress
  • Trembling or shaking
  • Palpitations, pounding heart, or accelerated heart rate
  • Parethesias (numbness or tingling sensation)
  • Sensations of shortness of breath or smothering
  • Sweating
  • Derealization or depersonalization
  • Fear of losing control
  • Fear of dying

Efficacy >>

Important Safety Information: XANAX XR is contraindicated in patients with known sensitivity to this drug or other benzodiazepines, in patients with acute narrow-angle glaucoma, and in patients taking potent CYP3A inhibitors, such as ketoconazole and itraconazole.

Certain adverse clinical events are a direct consequence of physical dependence to alprazolam. These include a spectrum of discontinuation symptoms, the most important being the possibility of seizure.

The most commonly observed adverse events in patients treated with XANAX XR in controlled clinical trials (≥5% and at least twice the incidence observed for placebo) were: sedation (45.2% vs 22.6%), somnolence (23.0% vs 6.0%), memory impairment (15.4% vs 6.9%), dysarthria (10.9% vs 2.6%), abnormal coordination (9.4% vs 0.9%), ataxia (7.2% vs 3.2%), and decreased libido (6.0% vs 2.3%).

Please see full prescribing information for more information.